Johnson & Johnson
JNJ Healthcare Drug Manufacturers General
Johnson & Johnson’s revenue for fiscal 2025 (year ended December 2025) was $94.2 billion, up 6.05% from fiscal 2024. In the quarter to September 2026, revenue grew 5.86%, EPS was flat, free cash flow grew 154.8% and total debt fell 4.82%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
Follow JNJ
Johnson & Johnson (JNJ) Operating margin
Johnson & Johnson's operating margin over the twelve months to 30 September 2026 was 19.3%, down 17.4 percentage points from fiscal 2025 (36.7%). Over the past ten years it has ranged from 20.1% (fiscal 2023) to 36.7% (fiscal 2025) — the current reading is the highest in ten years. That is in line with the Drug Manufacturers General industry median of 18.8% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 36.7% | 15.60 |
| FY2024 | 21.1% | 1.07 |
| FY2023 | 20.1% | (5.09) |
| FY2022 | 25.2% | 0.50 |
| FY2021 | 24.7% | 4.31 |
| FY2020 | 20.4% | (1.59) |
| FY2019 | 21.9% | (2.10) |
| FY2018 | 24.0% | (0.80) |
| FY2017 | 24.8% | (4.23) |
| FY2016 | 29.1% | 0.71 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 0.01% | (28.62) |
| Jun 2026 | 28.6% | 1.65 |
| Mar 2026 | 27.0% | 4.93 |
| Dec 2025 | 22.1% | (11.15) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| LLY Eli Lilly and Company compare | 42.2% |
| NVS Novartis AG compare | 30.2% |
| AMGN Amgen Inc. compare | 30.0% |
| ABBV AbbVie Inc. compare | 26.2% |
| AZN AstraZeneca PLC compare | 22.8% |
| PFE Pfizer Inc. compare | 21.7% |
| JNJ Johnson & Johnson | 19.3% |
| MRK Merck & Co., Inc. compare | 10.5% |
| GILD Gilead Sciences, Inc. compare | −8.20% |
| Drug Manufacturers General industry median | 18.8% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on JNJ
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement